Rivastigmine
- Product NDC
- 16714-115
- 11-digit product format
- 167140115
- Labeler code
- 16714
- Product ID
- 16714-115_d1c74c9f-51cd-4fdd-a49a-67cf6c8fe12d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Northstar Rx LLC.
- Application
- ANDA206318
- Marketing category
- ANDA
- Marketing start
- 2019-10-01
- Marketing end
- 0000-00-00
- Substance
- RIVASTIGMINE
- Active strength
- 5 mg/24h
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f5a24cc0-a293-4838-b663-7e454a66c2c3 | Product name | 5 | 20200513 |
| 64bcf1db-afe4-78b0-8e9c-f7cb25e1b791 | Product name | 6 | 20171121 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16714-115-01 | Rivastigmine | 24 h in 1 POUCH | PATCH, EXTENDED RELEASE | 24 | 7 | |
| 16714-115-02 | Rivastigmine | 30 in 1 CARTON | PATCH, EXTENDED RELEASE | 30 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16714-115-01 | EA - Each | 16714-115 | 5b2d8439-321d-43d4-82ab-57618c66fe67 | 1 | 2020-02-13 |
| 16714-115-02 | EA - Each | 16714-115 | 33426748-609e-4ec4-9164-91e15fa3b5ed | 1 | 2020-02-13 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | PSN | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725021 | rivastigmine 4.6 MG/Day 24HR Transdermal System | PSN | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725023 | rivastigmine 9.5 MG/Day 24HR Transdermal System | PSN | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725021 | 24 HR rivastigmine 0.192 MG/HR Transdermal System | SCD | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725023 | 24 HR rivastigmine 0.396 MG/HR Transdermal System | SCD | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 1308569 | 24 HR rivastigmine 0.554 MG/HR Transdermal System | SCD | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725021 | rivastigmine 0.192 MG/HR 24 HR Transdermal Patch | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725023 | rivastigmine 0.396 MG/HR 24 HR Transdermal Patch | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal Patch | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725021 | rivastigmine 4.6 MG/Day 24 HR Transdermal Patch | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725021 | rivastigmine 4.6 MG/Day 24HR Transdermal System | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725023 | rivastigmine 9.5 MG/Day 24 HR Transdermal Patch | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
| 725023 | rivastigmine 9.5 MG/Day 24HR Transdermal System | SY | 8b809739-8381-4cc1-ab4a-5b17ab902a3d | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 16714-115-01 | 16714011501 | 24 h in 1 POUCH | 24 h | Historical | ||||
| 16714-115-02 | 16714011502 | 30 POUCH in 1 CARTON (16714-115-02) > 24 h in 1 POUCH (16714-115-01) | 30 pouch | 2019-10-01 | 0000-00-00 | No | No | Current |